HCA Healthcare, Inc. HCA
502.46 USD -3.58 (-0.71%)
Nov 12, 2026, 3:27 PM EST
502.29 Day range 503.39
361.32 52-week range 545.13
- YTD
- +7.63%
- 1 year
- +6.09%
News
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to…
benzinga.com Michael Burry’s Portfolio: What the ‘Big Short’ Investor Owns Now Michael Burry expanded bets on Lululemon, Adobe, Sprouts, PayPal, MercadoLibre and JD.com, favoring buybacks and beaten-down value stocks.
businesswire.com HCA Healthcare Named a Best Employer for Veterans by Military Times for Seventh Consecutive Year NASHVILLE, Tenn.,--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been recognized for the seventh consecutive year as…
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to…
benzinga.com Here's How Much $100 Invested In HCA Healthcare 15 Years Ago Would Be Worth Today HCA Healthcare (NYSE:HCA) has outperformed the market over the past 15 years by 9.26% on an annualized basis producing an average annual return of 21.98%. Currently, HCA Healthcare has a market…
zacks.com Take the Zacks Approach to Beat the Markets: Ulta Beauty, Accenture, HCA in Focus Zacks highlights how its research strategies have delivered strong returns, with ACN, HCA and ULTA among the standout performers.
fool.com HCA Healthcare: 3 Key Takeaways for Long-Term Investors Same facility equivalent admissions increased 3% in the third quarter. HCA Healthcare repurchased approximately $3 billion of outstanding shares.
zacks.com Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact…
247wallst.com Hospital Stocks Soared as Democrats Took Congress HCA posted its biggest one-day jump in four years before a single law changed. Wall Street is pricing in relief that needs Congress, a presidential signature, and a December funding fight to survive.
zacks.com HCA Healthcare (HCA) Just Flashed Golden Cross Signal: Do You Buy? HCA Healthcare (HCA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, HCA broke through the 20-day moving average, which suggests a…
benzinga.com Truist Securities Reiterates Buy on HCA Healthcare, Raises Price Target to $510 Truist Securities analyst David Macdonald reiterates HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $495 to $510.
benzinga.com Here’s How Much You Would Have Made Owning HCA Healthcare Stock In The Last 15 Years HCA Healthcare (NYSE:HCA) has outperformed the market over the past 15 years by 8.97% on an annualized basis producing an average annual return of 21.51%. Currently, HCA Healthcare has a market…
benzinga.com Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $468 Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $381 to $468.
benzinga.com Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
benzinga.com RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $521 RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $496 to $521.
benzinga.com Barclays Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $401 Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $387 to $401.
benzinga.com TD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $486 TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $460 to $486.
benzinga.com HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results HCA Healthcare beat Q3 estimates: revenue rose 3.6% to $19.85B, EPS hit $7.22, and FY26 guidance increased; analysts raised price targets.
benzinga.com Keybanc Maintains Overweight on HCA Healthcare, Raises Price Target to $490 Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $435 to $490.- benzinga.com Baird Maintains Neutral on HCA Healthcare, Raises Price Target to $409 Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $393 to $409.
- benzinga.com B of A Securities Maintains Neutral on HCA Healthcare, Raises Price Target to $500 B of A Securities analyst Joanna Gajuk maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $450 to $500.
benzinga.com HCA Healthcare Beats Wall Street Estimates, But $400 Million Coverage Gap Trips the Stock HCA Healthcare beat Q3 2026 estimates and raised guidance, but shares slid following a $400 million pretax hit from rising uninsured patient volumes.
benzinga.com HCA Healthcare Q3 2026 Earnings Call Transcript HCA Healthcare (NYSE:HCA) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…- benzinga.com HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est HCA Healthcare (NYSE:HCA) raises FY2026 GAAP EPS guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 analyst estimate. Raises FY2026 sales outlook from $77.000 billion-$79.500 billion to $78.250…
benzinga.com Visa, Coca-Cola On Deck Tuesday As Payments Growth, Global Demand Face Test Visa is Tuesday’s most material report, with investors looking for continued payments growth after a strong run in the stock. Coca-Cola, HSBC Holdings, Novartis, Boeing and S&P Global report before…- benzinga.com TD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $460 TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $431 to $460.
- benzinga.com RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496 RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $435 to $496.
benzinga.com FTC Issues Letters Warning Hospitals Against Deceptive Pricing Practices https://www.ftc.gov/news-events/news/press-releases/2026/10/ftc-issues-letters-warning-hospitals-against-deceptive-pricing-practices
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.- benzinga.com BMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495 BMO Capital analyst Sean Dodge initiates coverage on HCA Healthcare (NYSE:HCA) with a Outperform rating and announces Price Target of $495.
- benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.- benzinga.com JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425 JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $490 to $425.
benzinga.com Jim Cramer Looked At This 'Not Great' Uranium Stock 'For Years' CNBC's Jim Cramer offers his takes on various companies, including CME Group, Alcoa, Rocket Lab, Fortinet, HCA Healthcare and Hubbell.- benzinga.com Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381 Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $369 to $381.
- benzinga.com Goldman Sachs Maintains Buy on HCA Healthcare, Lowers Price Target to $485 Goldman Sachs analyst Scott Fidel maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $558 to $485.
benzinga.com Mizuho Maintains Outperform on HCA Healthcare, Lowers Price Target to $475 Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $525 to $475.
benzinga.com This Congressman Slammed Elon Musk — Then Bought SpaceX Stock Multiple members of Congress disclose buying SpaceX stock, even some who aren't big fans of Elon Musk.- benzinga.com UBS Maintains Buy on HCA Healthcare, Lowers Price Target to $579 UBS analyst A.J. Rice maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $635 to $579.
benzinga.com Behind HCA's Q2 Beat: One-Time Medicaid Boost and a Growing Insurance Headwind HCA's Q2 results beat expectations. Company resets 2026 guidance on HIX headwinds and decline in surgeries.- benzinga.com Morgan Stanley Maintains Underweight on HCA Healthcare, Lowers Price Target to $380 Morgan Stanley analyst Craig Hettenbach maintains HCA Healthcare (NYSE:HCA) with a Underweight and lowers the price target from $425 to $380.
benzinga.com HCA Healthcare Analysts Slash Their Forecasts After Q2 Results HCA Healthcare's Q2 earnings beat expectations with $20.23B in revenue and adjusted earnings of $7.59 per share. Analysts lower price targets.- benzinga.com RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.
- benzinga.com Truist Securities Maintains Buy on HCA Healthcare, Lowers Price Target to $495 Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $535 to $495.
- benzinga.com Oppenheimer Maintains Outperform on HCA Healthcare, Lowers Price Target to $485 Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $520 to $485.
- benzinga.com Keybanc Maintains Overweight on HCA Healthcare, Lowers Price Target to $435 Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the price target from $475 to $435.
- benzinga.com Baird Maintains Neutral on HCA Healthcare, Lowers Price Target to $393 Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $396 to $393.
- benzinga.com Barclays Maintains Equal-Weight on HCA Healthcare, Lowers Price Target to $387 Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and lowers the price target from $402 to $387.